Skip to content

Drug interactions

Gilteritinib + Propafenone

Severity: Major

Gilteritinib and Propafenone: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Gilteritinib can prolong the QT interval and propafenone has proarrhythmic effects, so the combination raises the risk of serious ventricular arrhythmias including torsades de pointes.

What this interaction means in plain words

Gilteritinib and Propafenone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Gilteritinib belongs to Oncology; Propafenone belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Additive QT prolongation and proarrhythmic effects.

What to do

Avoid the combination where possible. If it is necessary, monitor ECG and electrolytes at baseline and during treatment and reduce or hold gilteritinib for significant QTc prolongation.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Gilteritinib and Propafenone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Gilteritinib with Propafenone?

MediHelp rates the interaction as major. Gilteritinib and Propafenone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Gilteritinib can prolong the QT interval and propafenone has proarrhythmic effects, so the combination raises the risk of serious ventricular arrhythmias including torsades de pointes.

How serious is the interaction between Gilteritinib and Propafenone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible. If it is necessary, monitor ECG and electrolytes at baseline and during treatment and reduce or hold gilteritinib for significant QTc prolongation.

What other medicines interact with Propafenone?

MediHelp also lists interactions of Propafenone with, for example, Dofetilide, Dronedarone, Nilotinib. The full list is on the Propafenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in